Clinical Trials Logo

Clinical Trial Summary

Objective To observe the safety and tolerability of Pazufloxacin Mesylate Ear Drops of different concentrations in patients with simple chronic suppurative otitis media.


Clinical Trial Description

The test group was completed in sequence from low to high concentrations, and safety tolerance was assessed after administration in one concentration group to determine whether to conduct follow-up group studies and, if necessary, adjust sampling time points according to pre-experimental results. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03675841
Study type Interventional
Source Lee's Pharmaceutical Limited
Contact lei chen, PHD
Phone 13776620807
Email jspent@126.com
Status Recruiting
Phase Phase 1
Start date July 29, 2018
Completion date June 28, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06160505 - Mastoid Obliteration Using S53P4 Bioactive Glass Versus Mastoidectomy Alone for Chronic Suppurative Otitis Media
Recruiting NCT02779907 - Prevalence and Associations of Paediatric Chronic Suppurative Otitis Media and Hearing Impairment in Rural Malawi N/A
Completed NCT05133258 - Antibiotic Concentration After Delivery to Middle Ear for Chronic Suppurative Otitis Media
Completed NCT05657717 - Safety Profile of Applied 100% Manuka Honey in Tympanoplasty Phase 2/Phase 3
Completed NCT05967845 - Platelet Rich Fibrin Augmented Tympanoplasty Versus Cartilage Tympanoplasty N/A